Publications by authors named "D Tavares De Resende E Silva Abate"
Article Synopsis
- Hydatid disease, caused by the Echinococcus parasite, is a serious health issue in endemic areas, and breast involvement is notably rare; this case involves a 34-year-old Ethiopian woman initially misdiagnosed with breast cancer.
- The patient presented with a painless swelling in her left breast that persisted for nine months, without symptoms typically associated with cancer, such as discharge or skin changes.
- Diagnostic imaging and tests ultimately confirmed that the mass was a hydatid cyst, highlighting the need for healthcare professionals to consider less common conditions in their diagnosis of breast masses in endemic regions.
Ethiopia Province has diverse forest resources. However, it has decreased over time, leaving the country's forest with only remnant patches. Therefore, the present study was conducted to examine the species composition, structure and regeneration status of woody plant species along disturbance gradients.
View Article and Find Full Text PDFUrinary tract infection (UTI) is a highly prevalent infection that can affect individuals of all ages, posing a significant risk to global health in terms of both morbidity and mortality. The emergence of multidrug-resistant bacteria adds to the complexity of this public health issue. There is limited data on the current study area.
View Article and Find Full Text PDFThe illicit traffic of cultural goods remains a persistent global challenge, despite the proliferation of comprehensive legislative frameworks developed to address and prevent cultural property crimes. Online platforms, especially social media and e-commerce, have facilitated illegal trade and pose significant challenges for law enforcement agencies. To address this issue, the European project SIGNIFICANCE was born, with the aim of combating illicit traffic of Cultural Heritage (CH) goods.
View Article and Find Full Text PDFBackground: The objective of this study was to expand data on cefiderocol efficacy to treat multidrug-resistant infections.
Methods: This was a retrospective monocentric study including patients hospitalized (>24 hours) at Policlinico Tor Vergata, Rome, Italy, between May 1, 2021, and September 1, 2022, treated with cefiderocol (>48 hours). The primary objective was early clinical improvement at 48-72 hours from cefiderocol start; secondary objectives were clinical success (composite outcome of infection resolution and 14-day survival), breakthrough infection, overall 30-day mortality, and cefiderocol-related adverse events.